Influence of dry granulation on compactibility and capping tendency of macrolide antibiotic formulation.
The effect of dry granulation (roller compaction and slugging) on compactibility and tablet capping tendency in a formulation with macrolide antibiotic and microcrystalline cellulose (MCC) was investigated. Direct tableting of this formulation revealed a pronounced capping tendency. Both dry granulated systems exhibit better compactibility and significant reductions in capping tendency compared to direct tableting. The capping tendency was also reduced through the use of precompression during direct tableting. The main volume reduction mechanism for macrolide antibiotic is fragmentation; this was confirmed by Heckel analysis, the lubricant sensitivity test, and SEM images. The yield pressure (Py) of the direct tableting system is lower than the Py of dry granulated systems, which indicates the lower plasticity of dry granulated systems. These findings do not explain the lower capping tendency of dry granulated systems compared to direct tableting. The main differentiating bonding mechanism is attributed to long distance intermolecular bonds due to the intense amorphization of macrolide antibiotic that occurs during dry granulation. Amorphization leads to a significant increase in surface free energy and consequently stronger long distance bonding between particles, which can withstand elastic relaxation and therefore reduce the capping problem. Solid bridges probably do not make a notable contribution to the mechanical strength of tablets, due to the brittle nature of the particles and the complex molecular structure of macrolide antibiotic.
Bozic
Damjana Zupancic
DZ
Krka d.d., Novo mesto, Smarjeska cesta 6, 8501 Novo mesto, Slovenia. damjana.zupancic@krka.biz
Dreu
Rok
R
Vrecer
Franc
F
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000737:chemistry*; D002152:Calorimetry, Differential Scanning; D002626:Chemistry, Pharmaceutical; D002849:Chromatography, Gas; D003890:Desiccation; D004339:Drug Compounding; D005079:Excipients; D006813:Humidity; D054327:Lubricants; D018942:Macrolides / Q000008:administration & dosage / Q000737:chemistry*; D008855:Microscopy, Electron, Scanning; D010316:Particle Size; D011208:Powders; D013607:Tablets; D014961:X-Ray Diffraction
D000900:Anti-Bacterial Agents; D005079:Excipients; D054327:Lubricants; D018942:Macrolides; D011208:Powders; D013607:Tablets